The place to be for startups

The lively mix of economic players and scientific institutions, the diverse selection of initiatives, the beneficial location factors and the growing number of IT companies make the German capital region a unique hub for start-ups and digital health solutions.

Over the last five years, more than 100 life sciences companies have been founded in Berlin-Brandenburg. This dynamic is still ongoing. Visible indicators include not only the number of new start-ups, but also the wide range of networking activities and services for start-up founders.

Would you like to found a startup?

With the following services we will accompany and support your startup project in the German capital region:

Do you want to internationalize your startup?

The Start Alliance is a program from Berlin Partner for Business and Technology and international partner cities. The goal of the Start Alliance is to accelerate market entry, to increase scaling effects, to adapt business models to international requirements and to accelerate corporate innovations. Through the Start-Alliance partnership, startups can access a program that facilitates rapid expansion among each destination.

Welcome to Berlin’s Startup Ecosystem

An increasing numbers of global players and companies based in Berlin are seeking to forge contacts with startups to invent new digital products and methods for the healthcare market. Berlin hosts over 60 accelerators and incubators, many of them with a strong focus on the healthcare sector; among them:

Bayer Grants4Apps Accelerator

Healthcare Hub Berlin from Pfizer

Flying Health incubator

helios.hub from the Helios Kliniken Gruppe

Startupbootcamp Digital Health

Heartbeat Labs

B Braun Accelerator

In addition, a large number of private and public investors and funding programs support the enormous development potential.

16. - 18.June 2020

18. June 2020

Since May 2017, the new EU regulation on In-vitro diagnostics 2017/746 has been in force and replaces the previous EU directive (98/79/EC). After a 5-year transition period, it will be binding for all in-vitro diagnostics manufacturers and economic...